01 — About

About the project

MBL Health partnered with a U.S. biotech sponsor to accelerate patient recruitment for a Congenital Adrenal Hyperplasia (CAH) gene therapy clinical trial.

We developed a scalable patient recruitment ecosystem designed to identify and engage eligible patients, streamlining recruitment and improving study site efficiency.

02 — Challenge

Recruiting for a rare disease gene therapy is uniquely complex.

The sponsor required a scalable recruitment strategy capable of expanding patient reach while delivering high-quality, trial-ready referrals.

01
Limited and geographically dispersed patient population
02

Low awareness of gene therapy clincal trial options

03

Complex eligibility criteria increasing screening drop-off

04

Reliance on traditional site-based recruitment

03 — Response

An Integrated Patient Recruitment Ecosystem

We launched omnichannel digital outreach campaigns that identified and engaged patients living with CAH, creating a scalable recruitment pipeline that supported patient enrolment into the CAH gene therapy trial

01

IRB-approved Patient Education

Developed IRB-approved educational materials that translated complex CAH and gene therapy concepts into clear, accessible language for patients and caregivers.

02

Digital Patient Experience

Designed and launched a study website with integrated online pre-screening, providing a seamless patient journey from education to study referral.

03

Omnichannel Outreach

Launched targeted campaigns across search, social media and patient communities to identify and engage individuals living with CAH.

04 — Precision Patient Recruitment

Finding eligible patients beyond traditional investigator networks

Our recruitment strategy combined real-time campaign optimisation, patient behaviour insights and recruitment analytics to continuously improve referral quality throughout the study.

Data-driven optimization

Continuously refined patient journeys, campaign performance and eligibility pathways using real-time recruitment data.

DupCheck+ Verification

Automatically detected duplicate registrations to improve recruitment quality and trial integrity.

JAVIS

Centralised patient data, recruitment analytics and referral workflows, providing sponsors with real-time operational visibility.

RESULTS AND IMPACT

Outcomes that moved the trial forward.

RESULTS AND IMPACT

430+

Patients recruited through digital campaigns

MBL Health's digital-first approach gave us a quality patient pipeline our traditional channels couldn't match — and at a pace our timeline required.

Clinical Operations Lead

Biotech sponsor, CAH program

Next chapter

Bring your
trial forward.

We help biotech and pharma teams build digital-first recruitment ecosystems for rare disease and gene therapy programs.